What is B-Secur?
B-Secur is a pioneering force in the health-tech industry, specializing in the advancement of heart health through its sophisticated HeartKey technology. The company provides an FDA-cleared universal ECG analytics software, HeartKey Rhythm, which is engineered to deliver high-precision rhythm detection and actionable clinical insights. By integrating seamlessly across both cloud and device platforms, B-Secur addresses the critical need for accurate, accessible cardiac monitoring. Their market position is defined by a focus on operational efficiency and clinical accuracy, serving as a vital partner for healthcare providers seeking to modernize patient care through data-driven diagnostics.
How much funding has B-Secur raised?
B-Secur has raised a total of $25.7M across 4 funding rounds:
Other Financing Round
$3.9M
Angel/Seed
$4.6M
Unspecified
$5.3M
Other Financing Round
$12M
Other Financing Round (2015): $3.9M with participation from Rudolf Wolff
Angel/Seed (2017): $4.6M led by Kernel Capital, Accelerated Digital Ventures, Woodford Investment Management, and British Business Bank
Unspecified (2019): $5.3M supported by Kernel Capital and Accelerated Digital Ventures
Other Financing Round (2021): $12M featuring First Capital Ventures
Key Investors in B-Secur
Kernel Capital
A venture capital and private equity firm specializing in growth-stage technology companies, providing both capital and strategic guidance to drive value creation.
Accelerated Digital Ventures
A firm operating within the custom software and IT services sector, focused on supporting innovation-driven businesses through strategic investment.
First Capital Ventures
An investment group specializing in healthcare and digital health technologies, utilizing a disciplined approach to support platform-driven innovation.
What's next for B-Secur?
With the recent influx of capital, B-Secur is poised to scale its commercial operations and deepen its research and development efforts. The strategic focus will likely center on enhancing the interoperability of its HeartKey platform and expanding its reach into new clinical environments. As the demand for remote patient monitoring and digital health solutions continues to surge, B-Secur is strategically aligned to capitalize on these trends, potentially driving further innovation in EKG interpretation and cardiac care management. The company remains focused on maintaining its competitive edge through rigorous clinical validation and technological refinement.
See full B-Secur company page
